Cornea

One ophthalmologist provides her pearls for managing cases of prolapsed iris and reconstructing it following trauma.

It is widely accepted that patient selection is the key to success with premium IOLs. However, with care, premium IOLs can be implemented in challenging cases.

Customised myopic LASIK using automated ray tracing optimisation has the potential to offer improved and more predictable outcomes, a study shows.

Studies show that corneal crosslinking could be a beneficial treatment in paediatric patients with keratoconus.

Topography-guided treatments for irregular corneas can improve patients’ best corrected visual acuity. The technique is easy to plan and perform, supported by software to do the calculations.

Topography-guided PRK, with or without the addition of corneal crosslinking, can improve visual acuity and quality in patients with keratoconus.

Cyclosporine for dry eye disease appears to be efficacious at all levels and the choice of which formulation to use usually depends on tolerability and affordability. Tolerability hinges primarily on the vehicle, which varies among different products.

In recent years, ophthalmologists have seen several new therapeutics for the treatment of dry eye disease.

The vicious cycle theory is a new way of understanding dry eye disease and may help improve prevention and treatment strategies.

In this roundtable, members of the Ophthalmology Times Europe® Editorial Advisory Board consider the top challenges and opportunities that they anticipate will affect ophthalmology in Europe in 2021.

A multifocal corneo-scleral contact lens that can correct presbyopia in irregular corneas has undergone a small pilot study. Complete visual rehabilitation was achieved along with a high degree of patient satisfaction.

The possibility of taking precise measurements of total corneal astigmatism enable more patients to be spectacle-free following cataract surgery.

Until we have a vaccine and see a reduction of COVID-19 cases down to zero, we must adjust and take every precaution possibly to protect our staff, as well as our patients.

Emerging data on conjunctivitis cases in COVID-19 patients necessitate high levels of caution and a meticulous approach during the pandemic.

Early identification, aggressive treatment critical; when to consider surgical intervention

Ocular allergy affects the quality of life of millions of people every year. Understanding the different mechanisms involved will increase their future therapeutic options.

The first human clinical trial to preliminarily evaluate the safety and efficacy of cellular therapy with mesenchymal stem cells for the corneal stroma has shown promise.

It is important with corneal angiography to remember that every patient is different so your technique might very slightly from patient to patient.

The European Commission has granted marketing authorisation for cenegermin eye drops (Oxervate, Dompé) for the treatment of moderate to severe neurotrophic keratitis.

Adding objective point-of-care dry eye diagnostics to your practice has deep, measurable effects, including more accurate and consistent IOL power calculations.

A committee of the European Medicines Agency has recommended approval of cenegermin (Oxervate, Dompé) eye drops for neurotrophic keratitis.

Mooren’s ulcers completely healed in 5 patients treated with rituximab after conventional treatment failed, according to researchers.

Failure to follow-up after ophthalmology appointments can damage patients’ health, a new study suggests. “In our view, national consideration should be given to create targets for reporting how well providers are managing follow-up patients,” reported A Davis and colleagues in the journal Eye.

Preliminary studies suggest disulfiram could aid in the treatment of mucous membrane pemphigoid (MMP). Used topically, the drug may inhibit aldehyde deydrogenase (ALDH), which plays a key role in fibrosis, wrote JK Dart, UCL Institute of Ophthalmology, London.

Chloramphenicol remains effective against Gram-positive bacteria, the most common agent in bacterial conjunctivitis, researchers say.